CEMAS – Leadership Team

Richard’s father, Michael, co-founded CEMAS in 1989 and Richard has had a close bond with the company since then. The Eustace family took full ownership of CEMAS in 1999 and Richard assumed the role of Chairman in 2019. Holding an M.A. in Chemistry from the University of Oxford, Richard helps drive the business’ strategic planning, direction and oversight.

Neal began his career as an analytical chemist, specialising in pesticide residue and flavour/taint analysis. He joined CEMAS a year after it was established, as an analyst and trainee study director. In 1999, he was appointed Technical Director on the board and took the position of Managing Director in 2019.  

Phil joined CEMAS in 2004 as a laboratory scientist and transitioned to managing the agrochemical and biocide product business in 2012. He became a director of CEMAS in 2014 and took on the role of Test Facility Manager in 2019, while continuing to oversee the products business.

Garry brings 28 years of experience in GLP laboratory operations, specialising in agrochemical residue analysis. He joined CEMAS in 2007, following a career in similar roles within the agrochemical industry. Initially working in the laboratory, Garry progressed to serve as Study Director and Principal Investigator on GLP studies, and now manages the Agrochemical Residues division. In 2014, Garry was appointed as a Director of CEMAS and continues to manage the residues business.

Erwan joined CEMAS in 2014 to lead the Pharmaceuticals division, bringing with him extensive experience from a career in quality control roles within the pharmaceutical industry. In 2023, he was promoted to the board of directors and continues to oversee the Pharmaceutical and Veterinary Medicine section of the business. 

Geraint joined CEMAS in 2011, bringing a wealth of experience from his work in the pharmaceutical and environmental industries. Since 2017, he has served as a director at CEMAS, overseeing IT operations and analytical method development.

Ashlene joined CEMAS in early 2020, taking on responsibility for quality assurance and management. She brings extensive expertise from her career in CRO GLP and GMP pharmaceutical manufacturing, where she began as a laboratory scientist before transitioning into Quality Assurance.